Suzuki, Kayo
Ishihara, Mami
Namba, Kenichi https://orcid.org/0000-0002-5016-851X
Ohno, Shigeaki
Goto, Hiroshi
Takase, Hiroshi
Kawano, Shigeru
Shibuya, Etsuko
Hase, Keitaro
Iwata, Daiju
Mizuuchi, Kazuomi
Kitaichi, Nobuyoshi
Mizuki, Nobuhisa
Ishida, Susumu
Article History
Received: 21 December 2021
Accepted: 21 April 2022
First Online: 21 June 2022
Conflicts of interest
: K. Suzuki, None; M. Ishihara, None; K. Namba, Grants or contracts (AbbVie, EPS, Mitsubishi Tanabe, Eisai), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Novartis, Kowa, Senju, Eisai, Celgene, Santen, Mitsubishi Tanabe, AbbVie, LEO Pharma, Otsuka, Chugai); S. Ohno, None; H. Goto, None; H. Takase, Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Santen, Novartis, AbbVie, Senju, Eisai, Otsuka); Patents planned, issued or pending (Japanese Patent Application No. 2019-107483); S. Kawano, None; E. Shibuya, None; K. Hase, None; D. Iwata, None; K. Mizuuchi, None; N. Kitaichi, Grant (Alcon); N. Mizuki, None; S. Ishida, Grants or contracts (Kyowa Kirin, Wakamoto, Nidek, HOYA, Nitto Medic, Advanced Medical Care, Chugai, Alcon, Bloom Technology, Kowa, Mylan EPD, Novartis, Bayer, Santen, Senju), Payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events (Alpha Communication, White Medical, Bloom Technology, AbbVie, Wakamoto, AMO, Otsuka, Senju, Seed, Alcon, Bayer, Santen, Nidek, Bonak).